Search Results - "Fly, K D"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

    A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer by Aglietta, M., Barone, C., Sawyer, M.B., Moore, M.J., Miller, W.H., Bagalà, C., Colombi, F., Cagnazzo, C., Gioeni, L., Wang, E., Huang, B., Fly, K.D., Leone, F.

    Published in Annals of oncology (01-09-2014)
    “…Tremelimumab (CP-675,206) is a fully human monoclonal antibody binding to cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) on T cells that stimulates the…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    A phase I dose escalation trial of CP-675206 (tremelimumab) in combination with gemcitabine in patients with chemotherapy-naive metastatic pancreatic cancer

    A phase I dose escalation trial of CP-675206 (tremelimumab) in combination with gemcitabine in patients with chemotherapy-naive metastatic pancreatic cancer by Aglietta, M., Barone, C., Muliello, M., Bagalà, C., Ferraro, D., Fly, K. D., Huang, B., Leone, F.

    Published in Journal of clinical oncology (20-05-2010)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC)

    A pooled analysis of the efficacy and safety of sunitinib in elderly patients (pts) with metastatic renal cell carcinoma (mRCC) by Hutson, T. E., Bukowski, R. M., Rini, B. I., Gore, M. E., Larkin, J. M. G., Figlin, R. A., Barrios, C. H., Escudier, B., Lin, X., Fly, K. D., Martell, B., Matczak, E., Motzer, R. J.

    Published in Journal of clinical oncology (20-05-2011)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Final toxicity results of a phase I dose-escalation trial of tremelimumab (CP-675206) in combination with gemcitabine in chemotherapy-naive patients (pts) with metastatic pancreatic cancer

    Final toxicity results of a phase I dose-escalation trial of tremelimumab (CP-675206) in combination with gemcitabine in chemotherapy-naive patients (pts) with metastatic pancreatic cancer by Aglietta, M., Barone, C., Sawyer, M. B., Moore, M. J., Miller, W. H., Bagalà, C., Ferraro, D. A., Colombi, F., Cagnazzo, C., Gioeni, L., Fly, K. D., Huang, B., Leone, F.

    Published in Journal of clinical oncology (20-05-2011)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    A phase I study of CD40 agonist monoclonal antibody (CP-870,893) with gemcitabine in pancreatic cancer

    A phase I study of CD40 agonist monoclonal antibody (CP-870,893) with gemcitabine in pancreatic cancer by Beatty, G. L., Chiorean, E. G., Torigian, D. A., Teitelbaum, U. R., Sun, W., Fly, K. D., Huhn, R. D., Vonderheide, R. H., O'Dwyer, P. J.

    Published in Journal of clinical oncology (20-05-2010)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer

    A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer by Aglietta, M, Barone, C, Sawyer, M B, Moore, M J, Miller, Jr, W H, Bagalà, C, Colombi, F, Cagnazzo, C, Gioeni, L, Wang, E, Huang, B, Fly, K D, Leone, F

    Published in Annals of oncology (01-09-2014)
    “…Tremelimumab (CP-675,206) is a fully human monoclonal antibody binding to cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) on T cells that stimulates the…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: